Anti-apoptotic actions of vasopressin in H32 neurons involve map kinase transactivation and bad phosphorylation
Anti-apoptotic actions of vasopressin in H32 neurons involve map kinase transactivation and bad phosphorylation
复制标题
DOI:
10.1016/j.expneurol.2008.02.023
复制
发表时间:
2008-06-01
影响因子:
5.3
通讯作者:
Aguilera, Greti
中科院分区:
文献类型:
--
作者:
Chen, Jun;Volpi, Simona;Aguilera, Greti
Vasopressin (VP) secreted within the brain modulates neuronal function acting as a neurotransmitter. Based on the observation that VP prevented serum deprivation-induced cell death in the neuronal cell line, H32, which expresses endogenous VI receptors, we tested the hypothesis that VP has anti-apoptotic properties. Flow cytometry experiments showed that 10 nM VP prevented serum deprivation-induced cell death and annexin V binding. Serum deprivation increased caspase-3 activity in a time and serum concentration dependent manner, and VP prevented these effects through interaction with receptors of VI subtype. The signaling pathways mediating the anti-apoptotic effect of VP involve mitogen activated protein (MAP) kinase and extracellular signal-regulated kinases (ERK), Ca2+/calmodulin dependent kinase (CaMK) and protein kinase C (PKC). Western blot analyses revealed time-dependent decreases of Bad phosphorylation and increases in cytosolic levels of cytochrome c following serum deprivation, effects which were prevented by 10 nM VP. These data demonstrate that activation of endogenous V1 VP receptors prevents serum deprivation-induced apoptosis, through phosphorylation-inactivation of the pro-apoptotic protein, Bad, and consequent decreases in cytosolic cytochrome c and caspase-3 activation. The data suggest that VP has anti-apoptotic activity in neurons and that VP may act as a neuroprotective agent in the brain. Published by Elsevier Inc.